The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Janet L. Stanford

Corresponding Author: Janet L. Stanford

Fred Hutchinson Cancer Research Center

M4-B874

PO Box 19024

[email]@fhcrc.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Corresponding Author: Janet L. Stanford, Fred Hutchinson Cancer Research Center, M4-B874, PO Box 19024. 2011
  • Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. 1999 - 2010
  • Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, and Department of Epidemiology, School of Public Health and Community Medicine, USA. 2006
  • Fred Hutchinson Cancer Research Center, Department of Epidemiology, University of Washington, Seattle 98109-1024, USA. 2000

References

  1. Genome-wide Association Study Identifies a Genetic Variant Associated with Risk for More Aggressive Prostate Cancer. Fitzgerald, L.M., Kwon, E.M., Conomos, M.P., Kolb, S., Holt, S.K., Levine, D., Feng, Z., Ostrander, E.A., Stanford, J.L. Cancer Epidemiol. Biomarkers Prev. (2011) [Pubmed]
  2. Genetic Variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality. Lin, D.W., Fitzgerald, L.M., Fu, R., Kwon, E.M., Zheng, S.L., Kolb, S., Wiklund, F., Stattin, P., Isaacs, W.B., Xu, J., Ostrander, E.A., Feng, Z., Grönberg, H., Stanford, J.L. Cancer Epidemiol. Biomarkers Prev. (2011) [Pubmed]
  3. Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. Salinas, C.A., Kwon, E.M., FitzGerald, L.M., Feng, Z., Nelson, P.S., Ostrander, E.A., Peters, U., Stanford, J.L. Am. J. Epidemiol. (2010) [Pubmed]
  4. Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage. Stanford, J.L., FitzGerald, L.M., McDonnell, S.K., Carlson, E.E., McIntosh, L.M., Deutsch, K., Hood, L., Ostrander, E.A., Schaid, D.J. Hum. Mol. Genet. (2009) [Pubmed]
  5. Prostate cancer and genetic susceptibility: a genome scan incorporating disease aggressiveness. Stanford, J.L., McDonnell, S.K., Friedrichsen, D.M., Carlson, E.E., Kolb, S., Deutsch, K., Janer, M., Hood, L., Ostrander, E.A., Schaid, D.J. Prostate (2006) [Pubmed]
  6. Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study. Stanford, J.L., Sabacan, L.P., Noonan, E.A., Iwasaki, L., Shu, J., Feng, Z., Ostrander, E.A. Cancer Epidemiol. Biomarkers Prev. (2003) [Pubmed]
  7. A polymorphism in the CYP17 gene and risk of prostate cancer. Stanford, J.L., Noonan, E.A., Iwasaki, L., Kolb, S., Chadwick, R.B., Feng, Z., Ostrander, E.A. Cancer Epidemiol. Biomarkers Prev. (2002) [Pubmed]
  8. Familial prostate cancer. Stanford, J.L., Ostrander, E.A. Epidemiol. Rev (2001) [Pubmed]
  9. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. Stanford, J.L., Feng, Z., Hamilton, A.S., Gilliland, F.D., Stephenson, R.A., Eley, J.W., Albertsen, P.C., Harlan, L.C., Potosky, A.L. JAMA (2000) [Pubmed]
  10. Vasectomy and risk of prostate cancer. Stanford, J.L., Wicklund, K.G., McKnight, B., Daling, J.R., Brawer, M.K. Cancer Epidemiol. Biomarkers Prev. (1999) [Pubmed]
 
WikiGenes - Universities